Medicines for Specific Cancers (E through L)

Drugs Approved for Endometrial Cancer

Megestrol

Drugs Approved for Esophageal Cancer

Docetaxel

Pembrolizumab

Ramucirumab

Trastuzumab

Trifluridine and Tipiracil Hydrochloride

Drugs Approved for Gastrointestinal Stromal Tumors

Imatinib

Regorafenib

Sunitinib

Drugs Approved for Head and Neck Cancer

Bleomycin

Cetuximab

Docetaxel

Hydroxyurea

Methotrexate

Nivolumab

Pembrolizumab

Drugs Approved for Hodgkin’s Disease

Bleomycin

Brentuximab Vedotin

Carmustine

Chlorambucil

Cyclophosphamide

Dacarbazine

Doxorubicin

Lomustine

Mechlorethamine

Nivolumab

Pembrolizumab

Prednisone

Procarbazine

Vinblastine

Vincristine

Drugs Approved for Kaposi Sarcoma

Doxorubicin

Paclitaxel

Recombinant Interferon Alfa-2b

Paclitaxel

Vinblastine

Drugs Approved for Kidney (Renal Cell) Cancer

Aldesleukin

Avelumab

Axitinib

Bevacizumab

Cabozantinib-S-Malate

Everolimus

Ipilimumab

Lenvatinib

Nivolumab

Pazopanib

Pembrolizumab

Sorafenib

Sunitinib

Temsirolimus

Drugs Approved for Acute Myeloid leukemia (AML)

Asparaginase
Blinatumomab
Calaspargase Pegol-mknl
Clofarabine
Cyclophosphamide
Cytarabine
Dasatinib
Daunorubicin
Dexamethasone
Doxorubicin
Inotuzumab Ozogamicin
Imatinib Mesylate
Mercaptopurine
Methotrexate
Nelarabine
Pegaspargase
Ponatinib
Prednisone
Tisagenlecleucel
Vincristine

Drugs Approved for Acute Lymphoblastic Leukemia (ALL)

Arsenic Trioxide
Cyclophosphamide
Cytarabine
Daunorubicin
Dexamethasone
Doxorubicin
Enasidenib
Gemtuzumab
Gilteritinib
Glasdegib
Idarubicin
Ivosidenib
Midostaurin
Mitoxantrone
Thioguanine
Venetoclax
Vincristine

Drugs Approved for Chronic Myeloid Leukemia (CML)

Alemtuzumab
Bendamustine
Chlorambucil
Cyclophosphamide
Dexamethasone
Duvelisib
Fludarabine
Ibrutinib
Idelalisib
Mechlorethamine
Obinutuzumab
Ofatumumab
Prednisone
Rituximab
Venetoclax

Drugs Approved for Chronic Lymphocytic Leukemia (CLL)

Bosutinib
Busulfan
Cyclophosphamide
Cytarabine
Dasatinib
Hydroxyurea
Imatinib Mesylate
Mechlorethamine
Nilotinib
Omacetaxine
Ponatinib

Drugs Approved for Liver Cancer

Cabozantinib-S-Malate

Lenvatinib

Nivolumab

Pembrolizumab

Ramucirumab

Regorafenib

Sorafenib

Drugs Approved for Non-Small Cell Lung Cancer

Afatinib

Alectinib

Atezolizumab

Bevacizumab

Brigatinib

Carboplatin

Ceritinib

Crizotinib

Dabrafenib

Dacomitinib

Docetaxel

Durvalumab

Erlotinib

Everolimus

Gefitinib

Gemcitabine

Lorlatinib

Mechlorethamine

Methotrexate

Necitumumab

Nivolumab

Osimertinib

Paclitaxel

Pembrolizumab

Pemetrexed

Ramucirumab

Trametinib

Vinorelbine

Drugs Approved for Small Cell Lung Cancer

Atezolizumab

Doxorubicin

Etoposide

Everolimus

Mechlorethamine

Methotrexate

Nivolumab

Topotecan

Other Cancers

Medicines Approved for Specific Cancers (A-D)

Medicines Approved for Specific Cancers (M-Z)